Lonely? Try Prescription4Love

Here I’ve been diving deep into the issues of partners, possibly neglecting all the single PWDs out there and their particular challenges. Well, today I found this: “Singles with special health conditions find cure for loneliness at Prescription4Love.com”
For real. It’s an Internet dating service that helps connect people with “special conditions” seeking companionship, including diabetes, cancer, STDs, hepatitis, impotence or a physical disability.
Here’s how they describe themselves: “Honesty and integrity are hallmarks at…

Read more »

INTRODUCING: The Diabetic Partner Follies

Periodically, I am reminded that we do not live with this disease alone. Our Loved Ones live with it, too, day in and day out. To be honest, I don’t often stop and think about what it might be like for them.
My exceptional partner has been urging me for some time to reach out to all the people out there living with diabetics — to give them a voice, and a forum for sharing…

Read more »

More Marketing Wars: Lantus vs. Levemir

Another larger-than-life Diabetes Marketing War, this time without the romantic names:
A while back I wrote a post introducing the first-ever competitor to Sanofi-Aventis’ long-acting insulin, Lantus. The new product is called Levemir, from Novo Nordisk.
What I missed more recently was that things turned ugly back in March. Sanofi filed suit against Novo Nordisk in a New Jersey U.S. District Court claiming that Novo was falsely promoting their drug as effective for 24 hours,…

Read more »

Wherefore Art Thou, Galvus and Januvia?

Are they not like the names of some star-crossed Shakespearean lovers? (the handsome, wistful Galvus persues the unobtainable Januvia…)
Well, get over it, ’cause these two new diabetes drugs are up-and-coming “blockbusters,” expected to create as much excitement as Exubera and Byetta — which is strange, actually, since these two of the Dramatic Names are just more pills for supressing insulin resistance.
But the New York Times says: “Wall Street analysts are bullish about Galvus…

Read more »

DexCom and Me Update: Managing Expectations

Today marks the close of Week One wearing the new DexCom STS wireless continuous monitor. I’m still enthusiastic, of course, but I’ve learned a few things, mostly about managing expectations. Or more specifically: Lessons in How CGM Can Help Us Now.
WHAT IT ISN’T:
- a magic wand for transforming your glucose control overnight (obviously, our rational minds know this beforehand, but somehow the vague hope lingers)
- an escape from multiple daily fingersticks. You…

Read more »